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Fusionles virus (MV) depends on an interaction between the hemagglutinin (H) and
fusion (F) glycoproteins. Amino acid substitutions in MV H that drastically reduce hemagglutinating activity
result in an increase in the amount of H (primarily the 74 kDa isoform) detectable in a complex with F at the
cell surface. This is in direct contrast to the loss of the ability to detect a complex between the fusion protein
of Newcastle disease virus and most attachment proteins that lack receptor binding activity. These opposing
results provide support for the existence of different mechanisms for the regulation of fusion by these two
paramyxoviruses.
© 2008 Elsevier Inc. All rights reserved.Introduction
The paramyxovirus family includes important human pathogens,
such as measles (MV), mumps, respiratory syncytial, and the various
parainﬂuenza viruses, as well as animal pathogens, such as canine
distemper virus, rinderpest virus, Newcastle disease virus (NDV), and
Sendai virus. The newly-emerged Hendra and Nipah viruses have also
been classiﬁed as paramyxoviruses. MV replication is initiated by
virion attachment to a target cell, which is mediated by binding of the
hemagglutinin (H) to either CD46 or CD150 (SLAM) (Dorig et al., 1993;
Erlenhoefer et al., 2001; Ono et al., 2001). As is the case for most
paramyxoviruses, MV fusion is regulated through a speciﬁc interaction
between H and the fusion (F) protein. However, the relationship
between receptor recognition by the attachment protein, the interac-
tion between the attachment and fusion proteins and the promotion
of fusion is still controversial (Deng et al., 1999; Li et al., 2004;
Melanson and Iorio, 2004, 2006; McGinnes and Morrison, 2006).
A great deal of evidence exists to support the idea that the stalks of
several paramyxovirus HN proteins determine the speciﬁcity for their
respective homologous F proteins (Deng et al., 1995; Melanson and
Iorio, 2004, 2006; Tanabayashi and Compans, 1996; Tsurudome et al.,
1995). Recently, with the identiﬁcation of a ﬁve-residue segment in the
stalk of MVH that is partially responsible for the selective triggering ofGenetics and Microbiology,
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rio).
ty of Florida, St. Augustine, FL,
l rights reserved.F variants, the importance of the stalk of the viral attachment protein in
mediating the interaction with F has been extended to the Morbilli-
viruses (Lee et al., 2008).
Despite the apparent conservation of this role for the stalk of the
HN/H protein, there is strong evidence that the relationship between
receptor binding and the interaction between the attachment and
fusion proteins may vary among different paramyxoviruses. ER co-
retention studies detect an intracellular interaction between MV H
and F (Plemper et al., 2001), but not between the humanparainﬂuenza
virus 3 or parainﬂuenza virus 5 hemagglutinin-neuraminidase (HN)
and F proteins (Paterson et al., 1997). Moreover, while mutations in
NDV HN that decrease fusion also decrease proportionally the extent
of the HN–F complex detectable at the cell surface (Melanson and
Iorio, 2004, 2006), there is no such correlation for MV H and F. Indeed,
there is strong evidence that there is an inverse relationship between
the extent of MV-induced fusion and the strength of the H–F
interaction (Plemper et al., 2002). Several mutations in the H stalk
that impair fusion independent of receptor binding result in an
increase in the extent of the H–F complex at the cell surface (Corey and
Iorio, 2007). Unlike NDV HN, no mutations in MV H have been
identiﬁed that abolish both fusion and the H–F interaction.
Thus, the relationship between the MV H–F complex and receptor
binding by H has not been directly examined. Here, we investigate the
effect of mutations in H that impair its ability to mediate hemadsorp-
tion (HAd) of African greenmonkey red blood cells (AGM RBCs) on the
extent of H–F complex formation at the cell surface. Our results
indicate that, again in direct opposition to the situation with NDV HN
and F, mutations in H that both impair binding to AGM RBCs and
decrease fusion result in an increase in the amount of the H–F complex
detected at the cell surface.
Fig. 2. Detection of complexes between V451E MV H and MV Fcsm at the cell surface by
co-IP assay. The lysates were split into two equal aliquots and subjected to the co-IP
protocol using a mixture of two MAbs against the H protein and a polyclonal antiserum
against the cytoplasmic tail of F (the ﬁrst lane in each pair) or the F antiserum alone (the
second lane in each pair). The amount of the mutated H protein that co-IPs with F is
determined densitometrically and expressed as a percentage of that of the wt protein
after normalization for differences in expression of F.
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Following the identiﬁcation of CD46 as a cellular receptor for MV,
several regions of MV H were identiﬁed that modulate receptor
binding. Mutations at MV H residues 451 and 481 reduced CD46
recognition by MV H (Lecouturier et al., 1999; Patterson et al., 1999).
Additionally, alanine substitutions in the region 473–477 decreased
the ability of MV H to hemadsorb AGM RBCs (Patterson et al., 1999).
Residue F431 was also identiﬁed as crucial to the recognition of CD46
by virtue of its diminished fusion in Vero cells, which express CD46,
but not in CHO cells expressing SLAM (Vongpunsawad et al., 2004).
In this study, several of these residues were mutated individually,
or in combination, to produce mutated MV H proteins with
deﬁciencies in HAd activity. Proteins carrying the following substitu-
tions were prepared by site-directed mutagenesis of the MV H gene
from the Edmonston strain: F431S, V451E, Y481N, I473A, P474A,
R475A, F476A, K477A, 473–477A, and 473–477A/Y481N.
Initially, the HAd activity of MV H carrying an individual mutation
of F431S, V451E or Y481N was determined. All three substitutions
result in a reduction in HAd, though the V451E mutation affects this
activity much less than the others (Fig. 1). The F431S and Y481N-
mutated proteins promote HAd at levels of only 26.8% and 17.2% of
wild-type (wt) H activity, though they are expressed at the cell surface
at levels of 45.5% and 56.9% of wt, respectively. Consistent with their
defects in receptor binding, both of these mutated proteins also
exhibit markedly reduced fusion promotion with F431S-mutated H
promoting 7.1% of wt fusion and Y481N-mutated H failing to promote
a detectable level of fusion (Fig. 1). The V451E-mutated protein
exhibits a somewhat different phenotype than the others. It is
efﬁciently expressed (95.3% of wt) and maintains a relatively high
level of HAd activity (65.5% of wt), but still exhibits a strong decrease
in the ability to promote fusion (1.4% of wt). Clearly, it exhibits a much
stronger deﬁciency in fusion promotion activity than can be attributed
to its deﬁciency in HAd, suggesting that its deﬁciency in fusion-
promoting activity may be traced to something other than, or in
addition to, receptor binding.
Since the V451E-mutated protein is expressed at a level compar-
able to wt H, it was assayed ﬁrst for the ability to co-IP with the F
protein (Fig. 2). The ﬁrst lane for each pair shows the maximum
amounts of the two biotinylated proteins that can be immunopreci-
pitated from the cell surface and reprecipitated with streptavidin,
while the second lane shows the percentage of total H one can co-IPFig. 1. Cell surface expression (CSE) and function of the MV H proteins with mutations
F431S, V451E and Y481N. All data points represent the mean of at least three
independent experiments and are expressed relative to the activity of the wt proteins.
For each assay, the background detected in cells transfected with vector has been
subtracted.with an antiserum to F (Corey and Iorio, 2007). The second and third
pairs of lanes demonstrate the speciﬁcity of the co-IP. (The ﬁlms are
slightly overexposed to conﬁrm this speciﬁcity.) The fourth pair of
lanes shows that both of the cell surface expressed glycosylation
isoforms of MV H with apparent molecular weights of 74 (immature
form) and 78 kDa (mature form) (Ogura et al., 1991, 2000) co-IP with F,
as previously demonstrated (Corey and Iorio, 2007). Surprisingly, the
V451E-mutated protein still co-IPs with F, despite the virtual absence
of fusion-promoting activity. Indeed, it actually co-IPs approximately
50% more efﬁciently than wt H.
Next, based on the ﬁndings of Patterson et al. (1999), all ﬁve residues
in the region 473–477weremutated to alanine. As shown in Fig. 3A, the
473–477A-mutated protein does not exhibit altered cell surface
expression (CSE) (92.1% of wt). However, the protein's HAd (1.1% of
wt) and fusion (undetectable) activities are severely compromised.
To determine if the phenotype of the 473–477A-mutated protein
can be attributed to any single mutation, MV H proteins carrying
individual alanine mutations in this domain were prepared. Each of
the mutated proteins has a CSE level similar to that of wt MV H (95.1–
107.8% of wt) (Fig. 3A). Mutation of either of the ﬁrst two residues, 473
or 474, does not cause a signiﬁcant decrease in either HAd or fusion.
Indeed, the P474A mutation slightly increases both HAd and fusion to
116.7% and 133% of wt, respectively. In contrast, mutation of each of
the three remaining residues, R475, F476 and K477A, decreases
binding to levels of 57.2%, 68.6%, and 20.4%, respectively. This suggests
that the last three residues in this region may have additive, possibly
even synergistic, effects on attachment. Consistent with their defects
in HAd, all three mutated proteins also exhibit signiﬁcantly reduced
fusion promotion ranging from 18.8% to 45.3%. Both glycosylation
isoforms of each of the mutated MV H proteins can be immunopre-
cipitated in a ratio similar to that of the wt protein (Fig. 3B).
In an attempt to maximize the disruption of CD46 binding by MV
H, the substitutions that result in the strongest reductions in HAd,
473–477A and Y481N, were introduced together. As shown in Fig. 3A,
the resulting protein exhibits almost complete absence of HAd and no
detectable fusion promotion activity. However, this mutated protein is
not detectable by ﬂow cytometry using the 80-11-B2 anti-H mono-
clonal antibody. The 74 kDa isoform is detectable by IP with an
antiserum against the MV H cytoplasmic tail, though surface
biotinylation was not employed in this IP (Fig. 3B).
In the recently published MV H crystal structure, the putative
binding sites for the antibody and CD46 are in close proximity (Colf et
al., 2007; Hashiguchi et al., 2007). Thus, it is possible that the failure to
detect the 74 kDa form by ﬂow cytometry with this antibody may
Fig. 3. Cell surface expression and function of MV H proteins with mutations within
region 473 to 477 and with combined mutation of 433–477 and 481. (A) All data points
represent the mean of at least three independent experiments and are expressed
relative to the activity of the wt proteins. (B) Immunoprecipitation of mutated MV H
proteins. The proteins were immunoprecipitated using an antiserum directed against
the cytoplasmic tail of H and displayed on SDS-PAGE under reducing conditions.
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combination of amino acid substitutions. However, it seems more
likely that the complete lack of the 78 kDa form of the 473–477A/
Y481N-mutated protein is due to a block in the formation of the
completely glycosylated MV H protein and that the lack of HAd and
fusion activity by this protein is likely due to a defect in expression of
the 78 kDa functional protein at the cell surface.
Thus, we now have available several mutated proteins, which
make it possible to examine the relationship between receptor
binding and the H–F complex at the cell surface. To this end, the
mutated proteins exhibiting the strongest defects in receptor
recognition, including K477A, Y481N, 473–477A, and 473–477A/
Y481N, were tested in the co-IP assay (Fig. 4). Despite dramatic
defects in HAd, all of the mutated proteins tested co-IP efﬁciently withFig. 4. Detection of formation of complexes between K477A, Y481N, 473–477A, and 473–4
performed as described in the legend to Fig. 2.F. Indeed, as was observed for the V451E-mutated protein, it is
noteworthy that a deﬁciency in fusion correlates with an increase in
the extent of the H–F complex detected at the cell surface for 3 of the 4
proteins, ranging from 38% (473–477A-mutated H) to almost 3-fold
(473–477A/Y481N-mutated H) (Fig. 4). Only the Y481N-mutated
protein does not exhibit this inverse correlation, raising the possibility
that this mutationmay indirectly modulate the interaction of H with F
by a different mechanism.
For most of the mutated MV H proteins, the immature 74 kDa form
of the protein forms a complex with F more efﬁciently than does the
mature 78 kDA form, even though both forms are expressed at the cell
surface. This is consistent with H and F forming a complex prior to the
complete maturation of H (Plemper et al., 2001). It appears that the
complex between F and immature H is stabilized for attachment-
deﬁcient H proteins. Since the immature form lacks HAd activity
(Ogura et al., 1991, 2000) and, thus, is presumably non-functional in
fusion, this could very well contribute to the fusion deﬁciency of these
proteins. Consistent with this, only the immature 74 kDa form of the
473–477A/Y481N-mutated protein, which lacks HAd and fusion
activity, is detected in the co-IP with F and in greatly increased
amounts relative to wt H (Fig. 4).
With respect to the 473–477A/Y481N-mutated protein, we do
know that the 74 kDa form of this protein is expressed at the cell
surface due to its presence in the co-IP, which detects only
biotinylated H proteins at the cell surface (Fig. 4, lanes 15 and 16).
This again is consistent with the anti-H MAb used in the ﬂow
cytometric studies recognizing only the mature 78 kDa form of the
protein and raises the caveat that our ﬂow cytometric analyses
performed with this antibody may be based only on the mature,
functional form of the protein. However, this should not pose a
problem because, with the notable exception of the 473–477A/Y481N-
mutated protein, both isoforms of all the other mutated proteins
appear to be expressed comparably to those of the wt protein (refer to
the total IP lanes for the mutated proteins in Figs. 2 and 4).
Having demonstrated, with a single exception, that a marked
decrease in fusion correlates with increased detection of the H–F
complex at the cell surface, we determined whether a similar
correlation could be demonstrated for mutated H proteins with less
signiﬁcant decreases in HAd and fusion. To this end, the R475A- and
F476A-mutated H proteins, which decrease HAd and fusion by
approximately one-half were tested for their abilities to co-IP with F
(data not shown). These two proteins co-IP with F at 82 and 75% of wt
H, respectively, suggesting that the inverse correlation between fusion
and HAd is not manifested at such moderately decreased levels of
these two activities. It will be informative to determine whether there
is an inverse correlation in the opposite direction, i.e. increased HAd/
fusion and decreased H–F complex formation. However, we have77A/Y481N mutants of MV H with MV Fcsm at the cell surface. The experiment was
4 Rapid Communicationidentiﬁed only one mutated protein (P474A) with only moderate
increases in HAd and fusion. More signiﬁcant increases in these two
activities are probably necessary to detect an effect on the extent of
the H–F interaction.
Discussion
In this study, we present evidence consistent with, not only the
formation of a complex between MV H and F at the cell surface
independent of CD46 recognition by H, but also a correlation of
decreased HAd and fusion-promoting activity with increased stability
of the H–F complex. This stands in direct contrast to our previous
results with attachment- and fusion-deﬁcient NDV HN proteins (Deng
et al., 1999; Li et al., 2004). For NDV, loss of receptor binding and fusion
correlateswith inability to detect the HN–F complex at the cell surface.
The results for MV are consistent with our previous ﬁndings that
mutations in the MV H stalk that decrease fusion increase the stability
of the H–F complex (Corey and Iorio, 2007). Again, this is in contrast to
our demonstration of a direct correlation between loss of fusion and
decreased detection of the NDV HN–F complex resulting from
mutations in a short stretch in theHN stalk (Melanson and Iorio, 2004).
For most of the attachment-deﬁcient H proteins, it is noteworthy
that the immature 74 kDa form of H co-IPsmore efﬁciently with F than
does the mature 78 kDa form. It appears that the complex between F
and immature, non-functional H is stabilized for attachment-deﬁcient
H proteins. The possibility exists that this could be causally related to
the defect in fusion; an increase in the association of F with an
immature form of H would compete for the amount of the mature,
functional H–F complex present at the cell surface.
These contrasting results for NDV and MV provide additional
support for the hypothesis of a differential mechanism for regulation
of the fusion activation of F in paramyxoviruses, such as NDV, which
recognize the abundant sialic acid moiety and those, such as MV, that
recognize speciﬁc protein receptors (Iorio and Mahon, 2008). The
properties of two newly-emerged paramyxoviruses, Nipah virus and
Hendra virus, also support this caveat. These viruses also recognize
speciﬁc receptors and their fusogenicities correlate inversely with the
relative avidities of the attachment protein–fusion protein (G–F)
complex (Aguilar et al., 2006). As has been suggested for Nipah virus
by Aguilar et al. (2006), it may be that NDV fusion is regulated by the
formation of the HN–F complex, whereas MV fusion is regulated by
the dissociation of the H–F complex. Thus, severely diminished ability
of H to bind receptors could be increasing the amount of the H–F
complex detected because receptor binding is the trigger for release of
H from F and progression to fusion. This hypothesis can be tested by
monitoring the state of the H/HN–F complex during the fusion
process, such as before/after cleavage and the addition of target cells.
Now that the structure of the MV H globular domain is available, this
hypothesis can be tested further with H proteins carryingmutations at
positions directly involved in the binding of either CD46 or CD150.
Materials and methods
Recombinant plasmids and site-directed mutagenesis
The H and F genes of the Edmonston MV strain were gifts of Dr.
Michael Oldstone (The Scripps Research Institute). The ligation of both
genes into the pBluescript SK(+) (pBSK) expression vector (Stratagene,
La Jolla, CA) has been described previously, as has the protocol for site-
directed mutagenesis (Corey and Iorio, 2007).
Antibodies
Polyclonal antiserum (Fcyt) to a peptide mimicking a region in the
cytoplasmic tail of MV F was initially a gift of Dr. Roberto Cattaneo and
was later prepared (Proteintech Group Inc., Chicago, IL). A mixture oftwo MAbs to the MV H protein was purchased commercially
(Chemicon, Temicula, CA). A hybridoma producing another anti-H
MAb, called 80-11-B2, was a gift of Dr. Paul Rota.
Transient expression
HeLa cells were maintained in Dulbecco's Modiﬁed Eagle
medium (DMEM) with high glucose, L-glutamine, and pyridoxine
hydrochloride supplemented with 10% fetal calf serum (FCS), 2 mM
L-glutamine, 0.1 mM MEM non-essential amino acids solution, 4 U/
ml penicillin and 4 mg/ml streptomycin. Wt and mutated proteins
were expressed using the vaccinia virus-T7 (vTF7-3) RNA polymer-
ase expression system, which drives expression of genes under the
control of the T7 promoter in pBSK as described previously (Corey
and Iorio, 2007).
Functional assays
All assays have been described in detail previously (Corey and Iorio,
2007). Brieﬂy, cell surface expression was determined by ﬂow
cytometry with a MAb speciﬁc for an epitope in the ectodomain of
MV H (80-11-B2; gift of Paul Rota). Expressionwas also analyzed by IP
with a polyclonal antiserumagainst the cytoplasmic tail ofMVH (Hcyt;
gift of Roberto Cattaneo). Transfected cells were starved and then
radiolabeled for 1 h followed bya fourhour-chaseprior to IP. The ability
to interact with CD46 was indirectly quantitated at 37 °C by HAd of
AGM RBCs. This assay routinely serves as a model for attachment to
CD46, as these cells have been shown to express a form of CD46 that is
recognized by MV H (Hsu et al., 1997). For each assay, the background
with vector was subtracted. The ability of mutated H proteins to
complement MV F in the promotion of fusion was quantitated using a
content mixing assay utilizing a trypsin-dependent form of F (Fcsm).
This protein was created by mutating the cleavage site of the
Edmonston strain F protein from RRHKR to RNHNR, as described by
Maisner et al. (2000) and Corey and Iorio (2007).
MV H–F complexes were detected at the surface of HeLa cells using
a membrane-impermeable biotinylation-based co-IP assay with
antibodies against the MV H ectodomain (Chemicon, Temicula, CA)
and MV F cytoplasmic tail (Fcyt) as previously published (Corey and
Iorio, 2007). In this assay, the Fcsm form of F was utilized without the
addition of trypsin to separate complex formation/stability from the
rest of the fusion process. This is based on the assumption that the
stability of the H–F complex is likely to be very different in fusing and
nonfusing monolayers, which would make it difﬁcult to compare the
amounts of the H–F complex present under the two conditions, i.e. the
complex is assumed to dissociate as fusion proceeds to its completion.
The total amount of each mutated H protein and Fcsm present at the
cell surface and the amount of H that co-IPs with F were determined
by densitometry. The data are expressed as the percentage of total H
that co-IPs with F and is expressed relative towt H after normalization
for differences in the amount of F.
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